This Solicitation opportunity from Department Of Defense was posted on July 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

RINGER'S INJECTION, LAC

Closed

SPE2DP-26-T-4395Federal

Submission Closed08/05/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Norethindrone and Ethinyl Estradiol Tablets SupplierThis subcontract involves the supply of FDA-regulated Norethindrone and Ethinyl Estradiol Tablets, USP, to support prime contractors on Department of Defense Medical Supply Chain projects. The supplier is responsible for manufacturing or sourcing tablets that adhere to USP standards, with each package organized into six cycles of 28 tablets. A total of 12 pharmaceutical tablet packages are required for delivery. To ensure compliance, all products must be produced in FDA-approved facilities. Packaging must strictly follow MIL-STD-2073-1E and Medical Marking Standard No. 1. This opportunity falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing of Emollient LotionThis subcontract involves the pharmaceutical manufacturing of emollient lotion for prime contractors supporting Department of Defense medical supply contracts. The scope of work requires the formulation and blending of non-sterile, homogeneous oil-in-water or water-in-oil emulsion lotions using industrial emulsification equipment. The final product must adhere to strict technical specifications, including a pH range of 5.0 to 8.1 and a viscosity between 10,000 and 20,000 CPS, while meeting NSN 6508010197181 standards. The contractor is responsible for blending water, oils, emulsifiers, and preservatives, as well as maintaining controlled room temperature storage for the materials. Deliverables may be provided in bulk or bottled formats. This opportunity is managed by the Medical Supply Chain Pharm FSA under NAICS code 325412, with the place of performance located at FPO 96607.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Acetone Test Tablet SupplierThis subcontract involves the supply of FDA-regulated Acetone Test Tablets for prime contractors supporting the Department of Defense Medical Supply Chain. The required tablets must feature a 5 mg/dL sensitivity for acetoacetic acid and ensure no reaction with beta-hydroxybutyric acid. Each order consists of one bottle containing 100 tablets under NSN 6550016666950, with strict adherence to MIL-STD-2073-1E and Medical Marking Standard No. 1 for packaging. The supplier is responsible for managing an 18-month shelf life, ensuring that all products are delivered within three months of their manufacture date. This procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF. Performance for this contract is centered in APO 96260-5479.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Chlorine Dioxide Water Purification TabletsThis subcontract involves the supply of stabilized chlorine dioxide water purification tablets to prime contractors supporting Department of Defense medical supply contracts through the Medical Supply Chain Pharm FSA. The requirement is for 100 packages of sealed tablets, with each package containing 10 individually sealed units. To ensure compliance, the tablets must contain no active chlorine or iodine and must strictly adhere to military specifications for first aid kit components under NSN 6850-01-530-3396. The procurement falls under NAICS code 325412 and is designated for performance at APO 96260-5479. Interested parties must submit their responses by the deadline of November 2, 2026, following the solicitation posted on October 27, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Omeprazole Extended-Release Capsules SupplyThis subcontract involves the supply of FDA-regulated Omeprazole Extended-Release Capsules for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for manufacturing or sourcing 20 mg delayed release capsules that adhere to NSN 6505-01-624-7068, ensuring a minimum remaining shelf life of 21 months. The contract requires the delivery of 17 bottles of medication, with packaging and labeling strictly following ASTM D3951 and Medical Marking Standard No. 1. To be eligible, the supplier must maintain active FDA registration and ensure full compliance with the Buy American Act. The performance of this contract is centered at Fort Bragg, with a response deadline set for November 2, 2026. This procurement falls under NAICS code 325412, focusing on the specialized production and distribution of pharmaceutical preparations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Kerlix Gauze Bandages (NSN 6510-00-058-3047)This subcontract involves the supply of white, rubberless, crimped, and stretchable Kerlix gauze bandages for prime contractors supporting Department of Defense Medical Supply Chain projects. The required bandages must measure 4.5 inches by 4 yards, be individually sealed, and be packaged in units of 100. All products must be manufactured or sourced in compliance with the Buy American Act and delivered FOB Destination to San Antonio, Texas. Strict adherence to quality and logistics standards is required, specifically MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1 for all labeling and packaging. The contract falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF. Interested parties must respond by November 2, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0189

Solicitation SPE2DP-27-T-0189 is a procurement request by the Defense Logistics Agency for Norethindrone and Ethinyl Estradiol Tablets, USP, identified by NSN 6505015062659. The requirement consists of multiple line items, including quantities of 3, 6, and 3 packages. Each package contains 168 tablets organized into six cycles of 28 tablets, with specific active ingredient dosages and inert tablets. The product is FDA regulated and must be stored at 25 degrees Celsius, with a non-extendable shelf life of 36 months. Delivery is required within five days after receipt of order, with FOB Destination terms, including a specific delivery location at Kadena Air Base in Okinawa, Japan. Compliance requires adherence to Medical Marking Standard No. 1 and MIL-STD-2073-1E for packaging and preservation. Items must be shipped in sealed unit containers within commercial exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract incorporates various federal and defense clauses, including the Buy American Act, safeguarding of covered defense information under DFARS 252.204-7012, and electronic invoicing via the Wide Area WorkFlow system. Offerors must be registered in the System for Award Management and comply with NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROXYPROPYL METHYLCE

Solicitation # SPE2DP-27-T-0185

Solicitation SPE2DP-27-T-0185 is a Small Business Set-Aside request for the procurement of Ocucoat Viscoelastic 1ML, a 2% hydroxypropyl methylcellulose ophthalmic solution (NSN 6505016331037). This FDA-regulated medical device is designed for high-volume, small-incision cataract surgery and lens inserter lubrication. The requirement consists of 5 boxes, with a delivery timeline of 79 days after receipt of order and an original required delivery date of October 27, 2026. Delivery is FOB Destination, with the final destination located at the USA Med Mat Ctr EUR in Kaiserslautern, Germany. The contract mandates strict quality and shelf-life compliance, requiring a non-extendable shelf life of 24 months per RS016. Packaging must be commercial and sealed to prevent damage, adhering to MIL-STD-2073-1E and DLA packaging requirements. Marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. The procurement is subject to various DFARS and FAR clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0186

Solicitation SPE2DP-27-T-0186, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of one bottle of Enrofloxacin Tablets (NSN 6509-01-487-5834). The medication is specified as 68 mg with a 7% concentration for veterinary use in dogs and cats, providing broad-spectrum antibacterial activity. The item is designated as Type I (Code Q) with a non-extendable shelf life of 36 months and must be stored at controlled room temperature. Delivery is required within 84 days after the date of order, with shipping terms set as FOB Destination to a facility in Kaiserslautern, Germany. The contract mandates strict adherence to quality and packaging standards, including MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. Special packaging instructions MPPWN00001 apply, and hazardous materials must be labeled according to the Hazard Communication Standard 29 CFR 1910.1200. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The procurement is subject to the Buy American and Balance of Payments Program (DFARS 252.225-7001) and requires compliance with cybersecurity reporting under DFARS 252.204-7012. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0188

Solicitation SPE2DP-27-T-0188 is a procurement for emollient lotion under NAICS code 325412, managed by the Defense Logistics Agency. The requirement consists of multiple line items, including 500 bottles for CLIN 0001 and 12 bottles for CLIN 0002, with an additional 250 bottles for CLIN 0003. The product must be a non-sterile, homogeneous oil-in-water or water-in-oil emulsion with a pH range between 5.0 and 8.1 and a viscosity of 10,000 to 20,000 CPS. Each unit consists of a 240 ML (8 FL OZ) bottle equipped with a dispenser cap. The lotion must contain water, a suitable oil, an emulsifier, and a preservative, and it must be stored at controlled room temperature. Delivery is required within 20 days after the order, with specific required delivery dates ranging from June 17, 2026, to July 20, 2026. Shipments are designated as FOB Destination to various locations, including the USS George Washington, USS Iwo Jima, and the USNS Mercy. Packaging must comply with MIL-STD-129 and Medical Marking Standard No. 1, with non-hazardous materials following ASTM D3951 and hazardous materials adhering to TQ requirement IP025 and FED-STD-313. Palletization must follow DLA requirement RP001. The contract incorporates various FAR and DFARS clauses, including the Buy American Act, Wide Area Workflow for electronic payments, and destination inspection requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and SupplyThis subcontract for Pharmaceutical Manufacturing and Supply involves the production and delivery of specialized pharmaceutical preparations for prime contractors supporting the Department of Veterans Affairs. The scope of work encompasses the entire manufacturing lifecycle, including the compounding of pharmaceuticals, rigorous quality control testing, packaging, and labeling, with final delivery to VA facilities. To qualify, providers must maintain pharmaceutical grade manufacturing facilities and clean rooms, ensuring full FDA approval and strict adherence to current Good Manufacturing Practice compliance. This opportunity is managed under the Department of Veterans Affairs Network Contract Office 22 and is categorized under NAICS code 325412.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6505--VA Long Beach Pylarify

Solicitation # 36C26227Q0072

The Department of Veterans Affairs Long Beach Healthcare System intends to award a sole source, firm-fixed-price delivery order for Pylarify (piflufolastat F18) radiopharmaceutical injections. This advanced diagnostic imaging agent is utilized by the Nuclear Medicine department in conjunction with PET/CT scans to identify prostate-specific membrane antigen (PSMA) in prostate tumors, lymph nodes, bones, and other organs. The procurement is categorized under NAICS code 325412, Pharmaceutical Preparation Manufacturing, which has a size standard of 1,300 employees. The government has identified Progenics Pharmaceuticals, Inc. as the intended contractor, as the product is available under the VA National Acquisition Center Contract Federal Supply Schedule 36F79725D0093, effective from April 1, 2025, through March 31, 2030. This action is being conducted in accordance with RFO Part 8.401 and GSAM/R 538.7104-3(b)(ii) and 538.7104-4 regarding items peculiar to one manufacturer. While this is not a formal solicitation, interested parties capable of providing the same items may submit a capabilities statement to Contracting Specialist Melissa Ramirez by November 3, 2026, at 10:00 AM Pacific Local Time.

262-NETWORK Contract Office 22 (36C262)

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4395 with a total order of 7 packing groups, equivalent to 84 individual units. The product is manufactured by B. Braun Medical Inc. with NDC 00264-7750-00 and is subject to FDA regulation. Packaging must comply strictly with Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Each unit must be sealed and packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the specified destination, which is FPO AP 96675. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure up to 40°C permitted. Packaging must adhere to DLA’s RP001 requirements and the latest DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. No hazard classification applies under FED-STD-313, so commercial packaging per ASTM D3951 is acceptable but subordinate to DLA standards. Delivery is required within 20 days of contract award, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is packing group (PG), with each PG containing 12 units. All markings, labeling, and palletization must conform to specified DLA and federal standards, and shipping instructions must follow DLAD Proc Note C19 and C20. The solicitation closed on August 5, 2026, with an original required delivery date of August 3, 2026.

General Info

B. Braun supplies 84 lactated Ringer’s 1000ML units in 12-unit packs, DLA-compliant, no shelf life extension, delivery due within 20 days to FPO AP 96675.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100477 BOX 1, FPO, AP, 96675, USA

Set-Aside

NONE

Documents

RFQ SPE2DP-26-T-4395 Medical Supply Chain Pharm FSA

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedJul 30

Solicitation

Notice updatedJul 30

The notice description changed.

Response DeadlineAug 5

Deadline has passed

Submission Closed

08/05/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Timothy Mccauley

contact@example.gov

+1 (555) 000-0000

Full Description

RINGER'S INJECTION,LACTATED
RINGER'S INJECTION LACTATED,USP, 1000ML, 12S
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product. RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 PG = 12 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number,
SPE2DP-26-T-4395
SECTION B
and item description. RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N L7500 B. BRAUN MEDICAL INC 11171 P/N NDC00264-7750-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017681996 0001 PG 6.000
NSN/MATERIAL:6505013306267
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N22250
USNS PILILAAU T AKR 304
UNIT 100477 BOX 1
FPO AP 96675
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
SPE2DP-26-T-4395
SECTION B
PR: 7017681996 PRLI: 0001 CONT’D
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N22250
USNS PILILAAU T AKR 304
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N222506206S089
RDD: 227
PROJ: LP5 TP 3
SUPP ADD: YSDECK SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 10
DIC: A41 DIST: U9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:08/03/2026
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7017684189 0001 PG 1.000
NSN/MATERIAL:6505013306267
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT PKGING DATA MIL-STD-2073-1E
SPE2DP-26-T-4395
SECTION B
PR: 7017684189 PRLI: 0001 CONT’D
SPECIAL NSN/Part Number: 6505-01-330-6267 Quantity: 6 PG Purchase Request: 7017681996QTY: 6 Delivery: 20 days ADO